BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 33308057)

  • 21. Identification of an epithelial-mesenchymal transition-related lncRNA prognostic signature for patients with glioblastoma.
    Yang X; Niu S; Liu J; Fang J; Wu Z; Ling S; Di G; Jiang X
    Sci Rep; 2021 Dec; 11(1):23694. PubMed ID: 34880375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An epithelial-mesenchymal transition-related long noncoding RNA signature correlates with the prognosis and progression in patients with bladder cancer.
    Tong H; Li T; Gao S; Yin H; Cao H; He W
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33289830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An EMT-related gene signature for the prognosis of human bladder cancer.
    Cao R; Yuan L; Ma B; Wang G; Qiu W; Tian Y
    J Cell Mol Med; 2020 Jan; 24(1):605-617. PubMed ID: 31657881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma.
    Wu G; Zhang M
    BMC Cancer; 2020 May; 20(1):456. PubMed ID: 32448271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery and Validation of an Epithelial-Mesenchymal Transition-Based Signature in Gastric Cancer by Genomics and Prognosis Analysis.
    Xu H; Wan H; Zhu M; Feng L; Zhang H; Su F
    Biomed Res Int; 2021; 2021():9026918. PubMed ID: 34746312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation of apoptosis-related signature and molecular subtype to improve prognosis prediction in osteosarcoma patients.
    Hong J; Li Q; Wang X; Li J; Ding W; Hu H; He L
    J Clin Lab Anal; 2022 Jul; 36(7):e24501. PubMed ID: 35576501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer.
    Dai W; Xiao Y; Tang W; Li J; Hong L; Zhang J; Pei M; Lin J; Liu S; Wu X; Xiang L; Wang J
    Front Genet; 2021; 12():661306. PubMed ID: 34249086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
    Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
    BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients.
    Zhang Z; Zheng S; Lin Y; Sun J; Ding N; Chen J; Zhong J; Shi L; Xue M
    BMC Cancer; 2020 Nov; 20(1):1135. PubMed ID: 33228590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and Validation of a Potent Multi-miRNA Signature for Prediction of Prognosis of Osteosarcoma Patients.
    Luo X; Tang J; Xuan H; Liu J; Li X
    Med Sci Monit; 2020 Feb; 26():e919272. PubMed ID: 32098942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Four-Pseudogene Classifier Identified by Machine Learning Serves as a Novel Prognostic Marker for Survival of Osteosarcoma.
    Liu F; Xing L; Zhang X; Zhang X
    Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Signature based on metabolic-related gene pairs can predict overall survival of osteosarcoma patients.
    Li LQ; Zhang LH; Yuan YB; Lu XC; Zhang Y; Liu YK; Wen J; Khader MA; Liu T; Li JZ; Zhang Y
    Cancer Med; 2021 Jul; 10(13):4493-4509. PubMed ID: 34047495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The lncRNA HNF1A-AS1 is a negative prognostic factor and promotes tumorigenesis in osteosarcoma.
    Cai L; Lv J; Zhang Y; Li J; Wang Y; Yang H
    J Cell Mol Med; 2017 Nov; 21(11):2654-2662. PubMed ID: 28866868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epithelial to Mesenchymal Transition Relevant Subtypes with Distinct Prognosis and Responses to Chemo- or Immunotherapies in Osteosarcoma.
    Zhou Y; Li G; Li H; Lai F; Duan P; Cheng M
    J Immunol Res; 2022; 2022():1377565. PubMed ID: 35836470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of an immune-related prognostic index associated with osteosarcoma.
    Yin CD; Hou YL; Liu XR; He YS; Wang XP; Li CJ; Tan XH; Liu J
    Bioengineered; 2021 Dec; 12(1):172-182. PubMed ID: 33371790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA FAL1 is a negative prognostic biomarker and exhibits pro-oncogenic function in osteosarcoma.
    Wang Y; Zhao Z; Zhang S; Li Z; Li D; Yang S; Zhang H; Zeng X; Liu J
    J Cell Biochem; 2018 Nov; 119(10):8481-8489. PubMed ID: 29987852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis.
    Lv Y; Wu L; Jian H; Zhang C; Lou Y; Kang Y; Hou M; Li Z; Li X; Sun B; Zhou H
    Front Immunol; 2022; 13():997765. PubMed ID: 36275664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma.
    Ma B; Li M; Zhang L; Huang M; Lei JB; Fu GH; Liu CX; Lai QW; Chen QQ; Wang YL
    Tumour Biol; 2016 Apr; 37(4):4445-55. PubMed ID: 26499949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A panel of eight mRNA signatures improves prognosis prediction of osteosarcoma patients.
    Wu B; Wang Z; Lin N; Yan X; Lv Z; Ying Z; Ye Z
    Medicine (Baltimore); 2021 Apr; 100(14):e24118. PubMed ID: 33832059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.